ATE170631T1 - Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase - Google Patents
Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphataseInfo
- Publication number
- ATE170631T1 ATE170631T1 AT94909759T AT94909759T ATE170631T1 AT E170631 T1 ATE170631 T1 AT E170631T1 AT 94909759 T AT94909759 T AT 94909759T AT 94909759 T AT94909759 T AT 94909759T AT E170631 T1 ATE170631 T1 AT E170631T1
- Authority
- AT
- Austria
- Prior art keywords
- alkaline phosphatase
- composition
- effects
- endogene
- reducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1866193A | 1993-02-17 | 1993-02-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE170631T1 true ATE170631T1 (de) | 1998-09-15 |
Family
ID=21789125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94909759T ATE170631T1 (de) | 1993-02-17 | 1994-02-14 | Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase |
Country Status (10)
Country | Link |
---|---|
US (1) | US5948630A (de) |
EP (1) | EP0636247B1 (de) |
JP (1) | JP3350730B2 (de) |
AT (1) | ATE170631T1 (de) |
AU (1) | AU6247494A (de) |
CA (1) | CA2118231A1 (de) |
DE (1) | DE69412940T2 (de) |
DK (1) | DK0636247T3 (de) |
ES (1) | ES2123774T3 (de) |
WO (1) | WO1994019691A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002020061A1 (fr) * | 2000-09-07 | 2002-03-14 | Tokyo Gas Company Limited | Preparations servant a diagnostiquer la fonction secretoire extrapancreatique |
US7888372B2 (en) * | 2001-03-23 | 2011-02-15 | National Institutes Of Health (Nih) | Compositions and methods for modulating bone mineral deposition |
JP4567326B2 (ja) * | 2003-12-24 | 2010-10-20 | 三菱化学メディエンス株式会社 | 全血を用いる測定法 |
US7749722B2 (en) | 2005-12-15 | 2010-07-06 | Mitsubishi Kagaku Istron, Inc. | Measuring method using whole blood |
EP1978363B1 (de) * | 2007-04-03 | 2010-02-24 | Sysmex Corporation | Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren |
JP5137620B2 (ja) * | 2007-04-03 | 2013-02-06 | シスメックス株式会社 | アルカリホスファターゼ標識検出用試薬キット、免疫測定用試薬キット及び免疫測定方法 |
US20090104634A1 (en) * | 2007-10-21 | 2009-04-23 | Abbott Laboratories | One-step immunoassays exhibiting increased sensitivity and specificity |
CN110194774B (zh) * | 2019-06-05 | 2021-12-28 | 苏州百灵威超精细材料有限公司 | 5,6-二氢-6-(2-萘基)咪唑并[2,1-b]噻唑草酸盐的制备方法 |
CN111289456B (zh) * | 2020-03-31 | 2023-04-07 | 西安交通大学第二附属医院 | 一种检测粪便及肠道组织中肠碱性磷酸酶iap的方法 |
JP2022045189A (ja) * | 2020-09-08 | 2022-03-18 | デンカ株式会社 | 偽陽性の抑制により特異性を改善した検査キット |
JP2022045047A (ja) * | 2020-09-08 | 2022-03-18 | デンカ株式会社 | 偽陰性の抑制により特異性を改善した検査試薬 |
CN113267390B (zh) * | 2021-05-11 | 2023-05-05 | 北京丹大生物技术有限公司 | 一种用于滤纸干血片的检测标志物洗脱液及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3325356A (en) * | 1965-08-20 | 1967-06-13 | Merck & Co Inc | Compositions and method for treating helminthiasis |
US4150141A (en) * | 1977-06-28 | 1979-04-17 | Johnson & Johnson | Treatment for scabies |
US4220153A (en) * | 1978-05-08 | 1980-09-02 | Pfizer Inc. | Controlled release delivery system |
US4517288A (en) * | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
US4543358A (en) * | 1982-12-13 | 1985-09-24 | American Cyanamid Company | Anthelmintic gel composition and a method for their preparation at ambient temperatures |
US4781920A (en) * | 1984-11-13 | 1988-11-01 | American Cyanamid Company | Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole |
US5135847A (en) * | 1988-11-18 | 1992-08-04 | Becton, Dickinson And Company | Substrate composition for alkaline phosphatase and method for assay using same |
US5124245A (en) * | 1989-02-09 | 1992-06-23 | Eastman Kodak Company | Wash composition, test kit and their use to determine a herpes simplex viral antigen |
US5279935A (en) * | 1990-03-01 | 1994-01-18 | Becton, Dickinson And Company | Method of immunossay including deactivation of endogenous alkaline phosphatase |
US5250295A (en) * | 1991-11-04 | 1993-10-05 | The Regents Of The Univ. Of California | Natural killer cell enhancing factor |
US5478753A (en) * | 1993-06-29 | 1995-12-26 | Pb Diagnostic Systems, Inc. | Positive calibrator/control composition for an IgM serology assay and an IgM serology assay |
-
1994
- 1994-02-14 DK DK94909759T patent/DK0636247T3/da active
- 1994-02-14 EP EP94909759A patent/EP0636247B1/de not_active Expired - Lifetime
- 1994-02-14 AT AT94909759T patent/ATE170631T1/de not_active IP Right Cessation
- 1994-02-14 ES ES94909759T patent/ES2123774T3/es not_active Expired - Lifetime
- 1994-02-14 CA CA002118231A patent/CA2118231A1/en not_active Abandoned
- 1994-02-14 DE DE69412940T patent/DE69412940T2/de not_active Expired - Fee Related
- 1994-02-14 AU AU62474/94A patent/AU6247494A/en not_active Abandoned
- 1994-02-14 JP JP51923594A patent/JP3350730B2/ja not_active Expired - Fee Related
- 1994-02-14 WO PCT/US1994/001906 patent/WO1994019691A1/en active IP Right Grant
-
1996
- 1996-08-05 US US08/689,004 patent/US5948630A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2123774T3 (es) | 1999-01-16 |
US5948630A (en) | 1999-09-07 |
EP0636247A1 (de) | 1995-02-01 |
DE69412940T2 (de) | 1999-05-12 |
DE69412940D1 (de) | 1998-10-08 |
WO1994019691A1 (en) | 1994-09-01 |
AU6247494A (en) | 1994-09-14 |
DK0636247T3 (da) | 1999-05-31 |
JP3350730B2 (ja) | 2002-11-25 |
JPH07506437A (ja) | 1995-07-13 |
EP0636247B1 (de) | 1998-09-02 |
CA2118231A1 (en) | 1994-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69730388D1 (de) | Metall-Keramik-Substrate von hoher Zuverlässigkeit für Halbleiter | |
DE69528528D1 (de) | Thrombin-inhibitoren | |
NO962269D0 (no) | Enzyminhibitorer | |
DE69620161D1 (de) | Thrombininhibitoren | |
AU6914798A (en) | Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin | |
DE69009088D1 (de) | Verbindungsverfahren für Schaltungen und Klebefilm dafür. | |
DE69008423D1 (de) | Dynamische Fixierung von Schweinsaortaklappen. | |
BR9707049A (pt) | Agentes anticoagulantes utilizáveis no tratamento de trombose | |
ATE170631T1 (de) | Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase | |
DE69308161D1 (de) | Beschichtungszusammensetzungen für nichtklebende oberflächen | |
ATE332919T1 (de) | Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen | |
DE69332770D1 (de) | Sulfonylalkanoylaminohydroxyethylaminosulfamidsäuren verwendbar als retrovirale Proteasehemmer | |
PT766557E (pt) | Composicoes de aplicacao topica compreendendo n-acetil-cisteina | |
DE69814444D1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
NO904463D0 (no) | Korrosjonsinhibitor. | |
NO982715D0 (no) | Endotel celle-proliferasjonsinhibitor og fremgangsmÕte for anvendelse | |
BR9711367A (pt) | Elemento estrutural eletrocer mico e processo para sua fabrica-Æo | |
DE69325323T2 (de) | Prüfeinrichtung, insbesondere zur Oberflächenkontrolle von Zigaretten | |
NO911999L (no) | Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp. | |
TR199701013T1 (xx) | Nitrik oksit synthas'�n�n inhibit�rleri olarak mercapto ve seleno t�revleri. | |
DE69431549D1 (de) | Verfahren zur Einebnung von Halbleiterbauflächen und durch dieses Verfahren hergestellte Bauelemente | |
DE3585238D1 (de) | Verfahren zur bestimmung des reduzierten zustands von nicotinamid-adenin-dinukleotid. | |
DE69133166T2 (de) | Inhibitoren von katalytischen antikörpern | |
FR2569569B1 (fr) | Exerciseur destine notamment au travail du grand ecart. | |
FI965289A (fi) | DP-1:n ja muiden DP-proteiinien estäjien määritys |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |